Dr. Michael Manns on a Possible Link Between Hepatitis C and Hepatocellular Carcinoma
Michael Manns, MD, explains the possible link between hepatitis C and hepatocellular carcinoma.
Michael Manns, MD, director, Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover in Germany, explains the possible link between hepatitis C and hepatocellular carcinoma.
Manns says that patients who contracted hepatitis C or cirrhosis have showcased a greater risk of developing hepatocellular carcinoma (HCC), though drawing a direct link between the virus and HCC is difficult due to treatment of the virus depleting the potential control group. He concludes by pointing out that if a link is to be drawn between Hepatitis C and HCC, further testing must be done.
Gasparetto Explains Rationale for Quadruplet Front Line in Transplant-Ineligible Myeloma
February 22nd 2025In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the CEPHEUS, IMROZ, and BENEFIT trials of treatment for transplant-ineligible newly diagnosed multiple myeloma.
Read More
Key Trials From ASH 2024 Impact Treatment for Plasma Cell Disorders Going Forward
February 20th 2025Peers & Perspectives in Oncology editorial board member Marc J. Braunstein, MD, PhD, FACP, discussed the significant advancements in multiple myeloma treatment at the 2024 ASH Annual Meeting and Exposition.
Read More
